August 7, 2019

Alverno Laboratories introduces the Prostate Health Index (PHI) calculation, enhancing prostate cancer detection during Prostate Health month. The PHI calculation, incorporating PSA, free PSA, and p2PSA values, offers improved specificity, reducing unnecessary biopsies. Additionally, Alverno addresses Biotin interference in immunoassays, providing insights into affected assays and FDA recommendations for healthcare providers to mitigate potential errors.